Abstract Human chorionic gonadotropin b (hCGb) promotes tumorigenesis in a variety of tumors including glioblastoma, breast and prostate cancer cells, etc. However, the involved mechanisms remain elusive. Distinct from the other tumors, glioblastoma is a highly invasive brain tumor; invasion causes high recurrence and mortality. Characterization of hCGb signaling is to determine therapeutic targets to inhibit invasion and lower recurrence. Through both a stable cell line over-expressing hCGb and hCGb standards, we tested hCGb signaling, migration and invasion in human glioblastoma U87MG cells. ELISA showed that hCGb secreted into culture medium at an amount of 237.8 ± 7.8 ng/10 7 cells in hCGb transfected stable cells after the cells were grown for 24 h. Through Western blot and Gelatin zymography, we found that hCGb standards phosphorylated ERK1/2 and upregulated MMP-2 expression in dose-and time-dependent manners. Meanwhile, overexpressed hCGb phosphorylated ERK1/2, and upregulated MMP-2 expression and activity, whereas ERK1/2 blocker PD98059 (25 lM) significantly decreased both ERK1/2 and MMP-2 expression and activity. In addition, in the same conditions as the signaling test, hCGb promoted cell migration and invasion, whereas the PD98059 diminished these effects. These findings demonstrated that hCGb phosphorylated ERK1/2 upregulating MMP-2 expression and activity leading to cell migration and invasion, suggesting that hCGb, ERK1/2 and MMP-2 are the potential targets to inhibit glioblastoma invasion.
Introduction
Human chorionic gonadotropin (hCG) is a glycoprotein hormone composed of noncovalently conjugated hCGa and hCGb, primarily used to detect pregnancy and pregnancyrelated disorders [1] . However, the free b subunit hCGb is predominantly produced by cancer cells [2] [3] [4] . Numerous studies have showed that hCGb in serum and tissues was elevated in the majority of cancers, such as renal, colorectal, ovarian, prostate, urothelial carcinoma, glioblastoma and pancreatic cancers. Moreover, hCGb was demonstrated to contribute to tumor invasion and metastasis [5] [6] [7] [8] [9] [10] . We have previously reported that hCGb downregulated E-cadherin leading to migration and invasion in prostate cancer cells [11] . In addition, in a separate study, we also demonstrated that hCGb activated ERK1/2 and MMP-2 leading to prostate cancer cell migration and invasion (unpublished). However, we did not know whether hCGb triggered the same signaling pathways. Therefore, we hypothesize that hCGb activates ERK1/2 and MMP-2 leading to cell migration and invasion in human glioblastoma U87MG cells.
Since hCGb induced migration and invasion, characterization of the molecular linkage is beneficial to find the therapeutic targets. It was reported that hCG induces phosphorylation of the extracellular signal-regulated kinases (ERK1/2) in a PKA-independent manner and is involved in cell proliferation and differentiation in endometrium [12] . Further, in BeWo choriocarcinoma cells hCG activates the phosphorylation of ERK1/2 in a dose-dependent manner [13] . Thus hCGb might activate ERK1/2 in human glioblastoma cells. Furthermore, it is well known that the degradation of extracellular matrix (ECM) is a key process in invasion [14] . Studies showed that ERK1/2 regulated proteolytic enzymes leading to tumor cell migration and invasion, and that the increased ERK1/2 activity was found in metastatic cancer cells [15, 16] . Besides, as a result of the extracellular stimuli, phosphorylated ERK1/2 might translocate to the nucleus and activate some transcriptional factors, including AP-1, Elk-1 and NF-jB to regulate gene transcription. Interestingly, many matrix metalloproteinases (MMPs) have AP-1 consensus sequence in the MMP gene promoter regions and the sustained ERK1/2 activation resulted in an increased production of proteolytic enzymes in the surrounding environment, and further caused the ECM degradation [17] [18] [19] . The MMPs are cation-dependent endopeptidases which are considered as essential proteases in the ECM degradation and remodeling [20, 21] . Studies showed that MMP expression was increased by activating ERK1/2 in the invasive carcinomas [17, 22, 23] . More studies showed that angiotensin II upregulated MMP-2 expression and activity leading to invasion through the phosphorylation of ERK1/2 in U87MG cells [24] . Moreover, hCG stimulated the secretion of MMP-2 and MMP-9 in a dose-dependent manner in cytotrophoblastic cells. Also, hCG stimulated production of active MMP-2 and increased migration and invasion in SGHPL-5 cells [25] . In addition, many studies proved that blockade of MMPs by synthetic and natural inhibitors (tissue inhibitors of matrix metalloproteinase, TIMPs) inhibit cell migration and invasion via the ERK1/2 pathway [26] [27] [28] . Therefore, we hypothesize that hCGb activates ERK1/2 and further activates MMPs to trigger cell migration and invasion.
Glioblastoma is the most common brain tumor with high mortality because the cancer cells strongly invade adjacent normal tissues [29] . Therefore, this study will help to establish anti-invasion therapy via targeting invasionrelated tumor markers against human glioblastoma.
Materials and methods

Materials
Human glioblastoma cell line (U87MG) was purchased from the Cell Resource Center, Peking Union Medical College (CRC/PUMC). Cells were maintained in DMEM medium (HyClone) supplemented with 10 % FBS (Invitrogen, Carlsbad, CA), 100 units/ml penicillin, and 100 lg/ml streptomycin (Invitrogen) at 37°C with 95 % air and 5 % CO 2 . The construct pVSneo-hCGb is a product of Stratagene (La Jolla, CA). Restriction enzymes, XhoI and SalI and T4 DNA ligase were purchased from Invitrogen. Geneticin (G418) to screen cells and crystal violet to stain cells were obtained from Sigma (St. Louis, MO). Transwell plates for migration and invasion assay were bought from BD Biosciences (Bedford, MA). Purified hCGb standards were purchased from Abcam (Hong Kong).
Establishment of stable cell lines
The control vector without hCGb cDNA was produced as described previously [11] . The construct containing the pVSneo-hCGb or pVSneo-vector cDNA was transfected into the U87MG cells using FuGene HD reagent (Roche, USA) following the manufacturer's instructions. After the cells were incubated at 37°C for 48 h, the cells were passaged by 1:10 into the selection medium containing geneticin (1.2 mg/ml). Then, the cells were incubated continually for 2 weeks and single-cell colonies were collected. The screened cells were cultured in selection medium (600 lg/ml geneticin) for 2 more weeks until no additional dead cells were viewed. The selected cells were maintained in medium containing 600 lg/ml geneticin to test hCGb signaling.
ELISA
The hCGb-transfected U87MG cells were incubated till 70 % confluency. Cells were washed for three times with serum-free DMEM medium. Then the cells were cultured in serum-free DMEM medium at different time points. The medium was collected at the indicated time points and the ELISA was done to test secreted hCGb via a b-hCG ELISA kit (DRG Diagnostics, New Jersey, USA) according to the manufacturer's instruction.
Quantitative PCR
Total RNA was isolated using TriZol Reagent (Invitrogen, USA). cDNA was transcribed using Reverse Transcriptase Kit (TaKaRa, China) with 1.5 lg of each DNA-free total RNA following the manufacturer's instruction. Quantitative RT-PCR was performed on a Stratagene Mx3000P instrument. For real-time thermal cycling, triplicate aliquots of cDNA were used in a reaction mixture that contained 250 nM of each primer in a reaction volume of 25 ll using the PrimeScriptTM RT reagent Kit (TaKaRa, China). The PCR cycling program was run with an initial predenaturation step at 94°C for 60 s, amplification followed by 40 cycles at 94°C for 30 s, 57°C for 30 s, 72°C 20 s. The primers used for quantitative PCR were as follows:
Western blot U87MG cells were collected and lysed with RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1 % NP-40, 1 % sodium deoxycholate and 0.1 % SDS) containing protease inhibitor cocktail (Thermo Scientific, USA). Whole cell lysates were centrifuged at 12,000 9 g for 15 min. Total protein concentration was determined by BCA Protein Assay Kit (invitrogen). Equal amounts (20 lg) of total protein were loaded on 10 % SDS-PAGE gels and transferred to nitrocellulose membranes. The membrane was blocked in 5 % BSA in TBS-T buffer for 1 h at room temperature; then the membrane was incubated overnight at 4°C with primary antibody against hCG (BioDesign International, Saco, ME), anti-MMP-2, anti-ERK1/2 and anti-phospho-ERK1/2, which were obtained from Cell Signaling Technology, Inc (Shanghai). After washing 3 9 10 min each, the membrane was probed with the fluorescence-labeled secondary antibody (LI-COR Bioscience, Lincoln, NE) for 1 h at room temperature. After three washes, the membrane was scanned in both the 700 and 800 channels using the Odyssey infrared imaging system (LI-COR Bioscience).
Gelatin zymography
Conditioned medium from an equal number of cells was prepared and separated by 10 % acrylamide gel electrophoresis containing 0.1 % gelatin (Sigma). The gels were washed in 2.5 % Triton X-100 solution at room temperature with gentle agitation to remove SDS and were soaked in reaction buffer (50 mM Tris-HCl, pH 7.5, 0.2 M NaCl, 5 mM CaCl 2 2H 2 O, and 0.02 % Brij-35, PH7.6) at 37°C for 40 h. After reaction, the gels were stained for 30 min with staining solution (0.5 % Coomassie Brilliant Blue, 25 % isopropanol, and 10 % acetic acid). Later the stained gel was destained with an appropriate Coomassie R-250 destaining solution (50 % methanol, 10 % acetic acid). In the area digested by matrix metalloproteinases, clear bands will turn up against a dark blue background.
Migration and invasion assay
Cell migration assay was done in a 24-well plate with cell culture inserts (8 lm pore, BD Falcon). Cells (1 9 10 5 ) prepared in 500 ll serum-free medium were seeded in the upper chamber and 1 ml DMEM medium with 10 % fetal bovine serum was placed in the lower chamber. The cells were incubated for 6 h. The non-migrated cells on the upper chamber were removed with a cotton swab. The migrated cells on the bottom of the chamber were fixed with 100 % methanol for 10 min at -20°C, and then stained with 0.5 % crystal violet solution (made in 25 % methanol) at room temperature for 10 min. The crystal violet solution was poured off and the cells were rinsed with distilled water until excess dye was removed. The migrated cells were photographed and quantified by counting the stained cells from five randomly selected fields per well, images were acquired with a Leica DM IRB microscope at 2009 magnification. Cell invasion was determined by the tumor invasion system (8 lm pore, BD BioCoat). The bottom of cell culture insert was coated with artificial basement membrane. Cells (1 9 10 5 ) were seeded as above and incubated for 12 h, the other procedures were the same as those in migration assay.
Results
Detection of hCGb
By transfection, we used the constructs containing the pVSneo-hCGb or pVSneo-vector (control) to establish two stable U87MG cell lines. The selected cells were maintained in the medium containing 600 lg/ml geneticin. To determine the expression of hCGb in transfected U87MG cells, both real-time PCR and Western blotting were performed after the cells were incubated for 24 h, respectively (Fig. 1a, b) . Compared with empty-vector transfected U87MG cells (UV), a significant expression of hCGb was detected in the hCGb transfected cells (UH), whereas the expression of hCGb was just a little in the UV (control) cells under the experimental conditions and the sensitivity of these detection systems. In fact, hCGb was expressed in U87MG cells [30] , ELISA might be needed to increase sensitivity of detection. After growing the UH cells for 24 h, ELISA showed that hCGb secretion into medium contained 237.8 ± 7.8 ng/10 7 cells (Fig. 1c) . These indicated that we successfully established two stable cell lines using U87MG cells and the amount of hCGb secreted into medium was increased in a time-dependent manner.
hCGb phosphorylated ERK1/2 in U87MG cells
In many cancer cell types, hCGb activated ERK1/2. First we tested ERK1/2 phosphorylation in hCGb treated U87MG cells. hCGb standards were added into the serum-free medium at different doses for 1 h. Western blot revealed that ERK1/2 phosphorylation was induced in a dose-dependent manner, and the degree of ERK1/2 phosphorylation increased to 175.3 % ± 39.4 SEM while treatment with 200 ng/ml hCGb control was set as 100 % (Fig. 2a) Furthermore, the ERK1/2 phosphorylation was determined and the level of phosphorylation was increased to 218.7 % ± 30.6 SEM at 30 min of treatment with 200 ng/ml hCGb (Fig. 2b) . Besides, ERK1/2 Fig. 2 hCG phosphorylated ERK1/2 in U87MG cells. a Non-transfected U87MG cells were treated with 0, 25, 50, 100, and 200 ng/ml hCG for 1 h. Western blot showed that hCG standards activated ERK1/2 in a dose-dependent manner. b Serum-free cultures were treated with 200 ng/ml hCG for 0, 5, 15, 30 and 60 min. Western blot showed that hCG standards activated ERK1/2 in a time-dependent manner. (c) The cells were pretreated with PD98059 (25 lM) 30 min and then incubated for 24 h with serum-free cultures, Western blot showed that hCG activated ERK1/2 and PD98059 diminished these effect. *P \ 0.05 versus control. Data were shown as mean ± SEM from three independent experiments b phosphorylation was significantly increased in UH cells versus UV cells. However, after inhibition of ERK1/2 with PD98059 (25 lM), a specific inhibitor, ERK1/2 phosphorylation was dramatically diminished (Fig. 2c) . These results indicated that hCGb activated ERK1/2 in a dose-and timedependent manner.
hCGb upregulated MMP-2 and increased MMP-2 activity
As we know, MMP-2 contributes to cell migration and invasion in some tumors. Therefore we investigated whether hCGb regulates MMP-2 in the transfected U87MG cells. hCGb standards were added into the serum-free medium at different doses, Western blot showed that hCGb upregulated MMP-2 in a dose-dependent manner; the level of MMP-2 expression was increased to peak 244.3 % ± 52.0 SEM when treated with 100 or 200 ng/ml hCGb control was set as 100 % (Fig. 3a) . To determine whether MMP-2 upregulation resulted from ERK1/2 phosphorylation, we treated the cells with PD98059 (25 lM), the expression of MMP-2 in UH cells was dramatically decreased (Fig. 3b) . Gelatin zymography revealed that hCGb stimulated accumulation of the active MMP-2 (64KD). Similar to the protein expression assay, the activity of MMP-2 was also reduced by PD98059 (25 lM) (Fig. 3c) .
hCGb promotes cell migration and invasion via ERK1/2
We reported hCGb induced cell migration and invasion in prostate cancer cells. However the involved mechanisms remain unclear. In order to investigate whether hCGb contributes to cell migration and invasion via ERK1/2, the migration and invasion assays in the absence or presence of PD98059 (25 lM) were performed. The experimental conditions were the same as those in signaling studies. Results showed that hCGb significantly promotes cell migration and invasion; whereas PD98059 significantly reduced cell motility in U87MG cells (Fig. 4a, b) . These results indicated that hCGb promotes cell migration and invasion via activating ERK1/2.
Discussion
hCGb was demonstrated to promote carcinogenesis and might be involved in tumor metastasis and poor prognosis [31] . Although we found that hCGb decreased E-cadherin leading to migration and invasion in human prostate cancer cells, we know very little regarding hCGb triggered signaling. In the present study, we demonstrated that hCGb phosphorylated ERK1/2 and increased MMP-2 expression and activity leading to migration and invasion in human a Non-transfected U87MG cells were treated with 0, 25, 50, 100, and 200 ng/ml hCG for 24 h. Western blot showed that standard hCG activated MMP-2 in a dose-dependent manner. The upper band is pro-MMP-2, 72KD; the lower band is active MMP-2, 64KD. b The UH and UV cells were pretreated with PD98059 (25 lM) 30 min and then incubated for 24 h with serum-free cultures, western blot showed that hCG activated MMP-2 and PD98059 diminished these effects. c The conditioned medium from the above treatment was collected for zymography assay. The results showed that hCG activated MMP-2 (active MMP-2, 64KD) and PD98059 reduced the effects. *P \ 0.05 versus control. Data were shown as mean ± SEM from three independent experiments J Neurooncol (2013) 111:237-244 241 glioblastoma cancer cells. Glioblastoma is the most common primary brain tumors and has the unusual potential to infiltrate the normal brain tissues leading to failure of surgery. In the present study, we planned to find a few key molecular targets related to invasion to inhibit glioblastoma by molecular targeting. These results might provide a new approach to prevent tumor recurrence and improve prognosis. Studies showed that ERK1/2 phosphorylation induced by some cytokines has been demonstrated to contribute to tumor proliferation, migration and metastasis [32] , and that hCGb promoted ERK1/2 phosphorylation in some cancer cell types [13, 33] . These are consistent with our results which hCGb induced invasion via ERK1/2 phosphorylation in a dose-and time-dependent manner in U87MG cells. Thus, we might inhibit tumor invasion by targeting the molecules in the ERK1/2 signaling. Particularly, in order to investigate how ERK1/2 signaling links to the downstream molecules, we tested MMP-2 expression and activity in response to hCGb. MMPs have been regarded as essential molecules promoting tumor cells to migrate during invasion and metastasis due to their features in degradation of the ECM and basement membrane of cells [34, 35] . In human Fig. 4 hCG promotes cell migration and invasion. Approximately 1 9 10 5 cells were seeded in the relative 24-well plate with cell culture inserts, the cells were stimulated with/without PD98059 (25 lM) for 6 h to test migration (a) and incubated for 12 h to invasion (b). Assays were performed as described in ''Materials and methods''. The results showed that hCGb significantly promotes cell migration and invasion, PD98059 reduced the effects. *P \ 0.05 versus no PD98059 group. Data were shown as mean ± SEM from three independent experiments brain tumor, the activity of MMP-2 and MMP-9, especially MMP-2, has been implicated to be associated with the malignancy of brain tumors [29, 36, 37] . Here, we found that hCGb significantly increased MMP-2 expression and activity, the expression and activity of MMP-2 were remarkably repressed by ERK1/2 blocker PD98059 in hCGb transfected U87MG cells. These indicated that hCGb induced MMP-2 upregulation resulted from ERK1/2 phosphorylation. In addition, hCGb induced both ERK1/2 phosphorylation and MMP-2 expression followed the same dose and time phases, indicating an essential linkage between ERK1/2 and MMP-2. Therefore, MMP-2 is a key target to inhibit tumor invasion by molecular targeting in hCGb treated glioblastoma cells. Studies showed that chlorotoxin inhibits glioma cell invasion via inhibiting MMP-2 expression and activity, thus this result will be perspective to use molecular drugs to inhibit invasion and lower recurrence [38] . Apart from the molecular linkage analysis, we also know the molecular mechanism to cause invasion. Theoretically, ERK1/2 might translocate to nucleus to activate transcription factor AP-1, which resides in the MMP-2 promoter region [18] . Our results indicated that hCGb triggered ERK1/2 activation might result in MMP-2 upregulation and increase MMP-2 activity via some transcription factors, such as AP-1 in human glioma cells. Similarly, the migration and invasion assays showed that hCGb promoted cell migration and invasion, and these results were reversed by ERK1/2 blocker, implying that hCGb triggered ERK1/2 activation contributes to cell migration and invasion. The question is whether MMP-2 expression upregulation and MMP-2 activity increase resulted in cell migration and invasion? Absolutely, it is well known that MMP-2 contributes to cell migration and invasion in almost all kinds of cancer cells [39, 40] .
Taken together, here we demonstrated that hCGb increased cell migration and invasion through ERK1/2 phosphorylation and MMP-2 upregulation. Furthermore, ERK1/2 signal pathway is essential for MMP-2 expression and activation in response to hCGb stimulation in glioblastoma cells. These results first gave a full profiling that hCGb triggered a complete signaling pathway to regulate glioblastoma migration and invasion. We have previously demonstrated that hCGb downregulated E-cadherin to induce cancer migration and invasion in human prostate cancer cells, suggesting that tumor invasion is involved in multiple signaling pathways and many signaling molecules. Nonetheless, these results will give us an insight into hCGb induced invasion and provide a new way to treat glioblastoma.
